Report Scope:
The scope of this study involves clinical testing, prognostic and monitoring markets for CTCs in cancer. The report also includes the clinical research segment as well as currently approved CTC tests and their markets. The regulatory environment, current technologies, new technologies, cancer incidence, market projections and market share, along with the latest trends and new developments in this area, are included to support the clinical testing market.
Based on cancer type, the market for circulating tumor cells diagnostics is segmented into breast cancer, colorectal cancer and prostate cancer.
Based on technology, the market for circulating tumor cells diagnostics is segmented into CTC enrichment and detection, CTC direct detection and CTC analysis.
Based on application, the market for circulating tumor cells diagnostics is segmented into clinical/liquid biopsy and research.
The report discusses the qualitative and quantitative factors influencing market growth. Market drivers, restraints and opportunities are discussed in the report.
This report discusses some of the major drivers and restraints in the market for circulating tumor cells diagnostics, and it surveys the competitive landscape as well as the key players' strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions. The report also includes company profiles of major vendors that include a company overview, key product offerings, financial statistics and recent developments. The report provides insights on market shares and upcoming regional demand for circulating tumor cells diagnostics.
Some of the major market players discussed in the report are Qiagen N.V., Biocept Inc., Greiner Bio One International GmbH, Precision Medicine Group LLC and Menarini Silicon Biosystems. For market estimates, data have been provided for the 2020 as the base year, with forecasts for 2021 through 2026. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
- 24 data tables and 49 additional tables
- An up-to-date review and analysis of the global markets for circulating tumor cell (CTC) diagnostics
- Analyses of the global market trends, with data from 2019-2021, and projections of compound annual growth rates (CAGRs) through 2026
- Highlights of the upcoming market opportunities in the CTC diagnostics industry, and areas of focus to forecast this market into various segments and sub-segments
- Evaluation and forecast the global CTC diagnostics market size, forecasted growth trends, and corresponding market share analysis by cancer type, technology, application, and region
- In-depth information concerning market drivers and challenges, latest technologies, breakthrough innovations, costs and benefits of CTC enrichment techniques, regulatory concerns, and clinical trials
- Statistical information (facts and figures) on cancer incidence and prevalence, global cancer related deaths, and new cases of cancer by type in the United States
- Review of recent industry trends, value chain analysis, competitive landscape, and COVID-19 implications within the marketplace
- Descriptive company profiles of the leading global players, including Bio-Techne Corp., Biocept Inc., Greiner Bio-One International GmbH, Precision Medicine Group LLC, Menarini Silicon Biosystems, and Qiagen N.V.
Summary:
The global market for circulating tumor cells diagnostics was valued at REDACTED in 2020. By cancer type, this market has been segmented into breast cancer, colorectal cancer and prostate cancer. The breast cancer segment recorded REDACTED in revenue in 2020 and is estimated to grow at a compound annual growth rate (CAGR) of REDACTED during the forecast period. The fast growth rate of the colorectal cancer segment is attributed to rapid rise in the incidence of colorectal cancer, especially young adults. The growing prevalence of cancer, as circulating tumor cells find their applications in the diagnosis of cancer and precision management; advancements in technologies such as NGS and immunofluorescence; and growing awareness about the novel diagnostic methods for cancers are all major factors that will boost market growth.
Reasons for Doing this Study
This study was conducted to provide detailed information regarding new developments, prognostic and clinical research testing for circulating tumor cells. There is an increasing need for new and innovative technologies in this area. This industry is experiencing tremendous growth; the use of new prognostic technologies based on circulating tumor cells has increased in the past few years.
This BCC Research study will increase awareness of current and emerging technologies and practices for cancer and cancer research, especially for prostate, breast and colorectal cancers.
Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets
Table of Contents
Chapter 1 Introduction
Study Background
Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
What's New in this Update?
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Cancer
Recent Advances in Technology
Invasive Power
Circulating Tumor Cells
Phenotypic Characteristics
CTC Clusters
CTC Detection
Cancer Stem Cells (CSCs)
Circulating Tumor Cells -- Potential Uses
Proliferative Activity
Epithelial Marker Genes on Circulating Tumor Cells
Circulating Tumor Cells and Stem Cell-Like Phenotype
CTCs and Primary Tumor Cells: A Comparison
Metastasis
Future Directions
Metastatic Development in Cancer Patients
Circulating Tumor Cell Migration
Circulating Tumor Cell Detection
Methods
CellSearch Method
Epic Sciences Method
Maintrac
ISET Test
Challenges for Detection
Clinical Application of Circulating Tumor DNA
Circulating Tumor Cells as Predictor of Response to Therapy
Measurement of CTCs -- Applications
Conclusion
Chapter 4 CTC Diagnostic Technologies
Finding Circulating Tumor Cells
Why CTCs?
Current CTC Detection and Isolation Methods
New Technologies for Detection
Cancer Prognosis
Nucleic Acid-Based Methods
Clinical Testing
Summary
New Emerging Technologies
Chapter 5 Impact of COVID-19 on the CTC Diagnostics Market
Overview
COVID-19 and Cancer Screening
Impact of COVID-19 on Company Revenues
Chapter 6 Market Dynamics
Market Drivers
Rising Incidence of Cancer Worldwide
Advantages Offered, by Noninvasivene Approach, by Circulating Tumor Cells
Advancements in NGS and Immunofluorescence Technologies
Growing Awareness About the Novel Diagnostic Methods for Cancers
Market Restraints
High Costs of CTC Diagnostics
Rarity of CTCs in Blood Samples and Lack of Skilled Professionals for CTC Diagnostics
Market Opportunities
Circulating Tumor Cells as a Therapeutic Target
Competitive Landscape
Chapter 7 Market Breakdown by Cancer Type
Global Market for CTC Diagnostics by Cancer Type
Breast Cancer
Colorectal Cancer
Prostate Cancer
Chapter 8 Market Breakdown by Technology
Global Market for CTC Diagnostics by Technology
CTC Enrichment and Detection
CTC Direct Detection
CTC Analysis
Chapter 9 Market Breakdown by Application
Global Market for CTC Diagnostics by Application
Clinical/Liquid Biopsy
Research
Chapter 10 Market Breakdown by Region
Global Market for CTC Diagnostics by Region
North America
Europe
Asia-Pacific
Rest of World
Chapter 11 Company Profiles
BIO-TECHNE CORP. (ADVANCED CELL DIAGNOSTICS INC.)
BIOCEPT, INC.
BIOFLUIDICA
CREATV MICROTECH INC.
FLUXION BIOSCIENCES, INC.
GREINER BIO-ONE INTERNATIONAL GMBH
IKONISYS, INC.
IVDIAGNOSTICS, INC.
MENARINI SILICON BIOSYSTEMS (FORMERLY VERIDEX LLC)
MILTENYI BIOTEC
PRECISION MEDICINE GROUP LLC
QIAGEN N.V.
RARECELLS, INC.
SCREENCELL
STEMCELL TECHNOLOGIES INC.
Chapter 12 Appendix: List of Acronyms
List of Tables
Table A : New Additions to the Updated Version of the Report
Summary Table : Global Market for Circulating Tumor Cells (CTC) Diagnostics, by Cancer Type, Through 2026
Table 1 : Categories of Stem Cells
Table 2 : Product Categories
Table 3 : Key Characteristics of CTCs
Table 4 : Types of CTCs
Table 5 : Circulating Tumor Cells Features
Table 6 : Metastatic Cascade
Table 7 : EPCAM-Based Assays
Table 8 : Comparison of Different Liquid Biopsy Technologies
Table 9 : Potential Applications of CTC-Based Diagnostics
Table 10 : Clinical Relevance of CTC
Table 11 : CTC Enrichment Methods
Table 12 : Techniques Used for CTC Enrichment
Table 13 : Techniques Used for CTC Analysis
Table 14 : Enumeration Techniques
Table 15 : Functional Assays
Table 16 : Circulating Tumor Cells Technologies
Table 17 : Micro-Count Features: A New Technology
Table 18 : Ranking of Global Vendors of CTC Diagnostics, 2020
Table 19 : Global Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 20 : Global Market for CTC Diagnostics for Breast Cancer, by Region, Through 2026
Table 21 : Global Market for CTC Diagnostics for Colorectal Cancer, by Region, Through 2026
Table 22 : Global Market for CTC Diagnostics for Prostate Cancer, by Region, Through 2026
Table 23 : Global Market for CTC Diagnostics, by Technology, Through 2026
Table 24 : CTC Enrichment Methods
Table 25 : Global Market for CTC Enrichment and Detection, by Region, Through 2026
Table 26 : Global Market for CTC Direct Detection, by Region, Through 2026
Table 27 : Global Market for CTC Analysis, by Region, Through 2026
Table 28 : Global Market for CTC Diagnostics, by Application, Through 2026
Table 29 : Global Market for CTC Diagnostics in Clinical/Liquid Biopsy Applications, by Region, Through 2026
Table 30 : Global Market for CTC Diagnostics in Research Applications, by Region, Through 2026
Table 31 : Global Market for CTC Diagnostics, by Region, Through 2026
Table 32 : North American Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 33 : North American Market for CTC Diagnostics, by Country, Through 2026
Table 34 : Estimated Number of New Cases and Age-Standardized Incidence Rates for Cancers in Canada, by Sex, 2020
Table 35 : European Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 36 : European Market for CTC Diagnostics, by Country, Through 2026
Table 37 : Asia-Pacific Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 38 : Asia-Pacific Market for CTC Diagnostics, by Country, Through 2026
Table 39 : Age-Standardized Cancer Incidence and Mortality Rates in China, by Gender, 2018
Table 40 : Rest of World Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 41 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): R&D Expenditures, 2018-2020
Table 42 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Products Offered
Table 43 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Recent Developments
Table 44 : Biocept, Inc.: R&D Expenditures, 2019 and 2020
Table 45 : Biocept, Inc.: Solutions/Services Offered
Table 46 : Biocept, Inc.: Recent Developments
Table 47 : BioFluidica: Solutions/Services Offered
Table 48 : BioFluidica: Recent Developments
Table 49 : Creatv MicroTech Inc.: Products Offered
Table 50 : Creatv MicroTech Inc: Recent Developments
Table 51 : Fluxion Biosciences, Inc.: Solutions/Services Offered
Table 52 : Fluxion Biosciences, Inc.: Recent Developments
Table 53 : Greiner Bio-One International GmbH: Products Offered
Table 54 : Ikonisys, Inc.: Products Offered
Table 55 : Ikonisys, Inc.: Recent Developments
Table 56 : IVDiagnostics, Inc.: Products/Services Offered
Table 57 : IVDiagnostics, Inc.: Recent Developments
Table 58 : Menarini Silicon Biosystems: Products Offered
Table 59 : Menarini Silicon Biosystems: Recent Developments
Table 60 : Miltenyi Biotec: Products Offered
Table 61 : Precision Medicine Group LLC: Products Offered
Table 62 : Precision Medicine Group LLC: Recent Developments
Table 63 : Qiagen: Products Offered
Table 64 : Qiagen: Recent Developments
Table 65 : Rarecells, Inc.: Products Offered
Table 66 : Rarecells, Inc.: Recent Developments
Table 67 : ScreenCell: Products Offered
Table 68 : ScreenCell: Recent Developments, 2021
Table 69 : STEMCELL Technologies Inc.: Products/Services Offered
Table 70 : STEMCELL Technologies Inc.: Recent Developments
Table 71 : Commonly Used Acronyms in the Market for CTC Diagnostics
List of Figures
Summary Figure : Global Market Shares of Circulating Tumor Cells (CTC) Diagnostics, by Cancer Type, 2020
Figure 1 : Global Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 2 : Global Market for CTC Diagnostics for Breast Cancer, 2019-2026
Figure 3 : Global Market for CTC Diagnostics for Breast Cancer, by Region, 2019-2026
Figure 4 : Global Market for CTC Diagnostics for Colorectal Cancer, 2019-2026
Figure 5 : Global Market for CTC Diagnostics for Colorectal Cancer, by Region, 2019-2026
Figure 6 : Global Market for CTC Diagnostics for Prostate Cancer, 2019-2026
Figure 7 : Global Market for CTC Diagnostics for Prostate Cancer, by Region, 2019-2026
Figure 8 : Global Market Shares of CTC Diagnostics, by Technology, 2020
Figure 9 : Global Market for CTC Enrichment and Detection, 2019-2026
Figure 10 : Global Market for CTC Enrichment and Detection, by Region, 2019-2026
Figure 11 : Global Market for CTC Direct Detection, 2019-2026
Figure 12 : Global Market for CTC Direct Detection, by Region, 2019-2026
Figure 13 : Global Market for CTC Analysis, 2019-2026
Figure 14 : Global Market for CTC Analysis, by Region, 2019-2026
Figure 15 : Global Market Shares of CTC Diagnostics, by Application, 2020
Figure 16 : Global Market for CTC Diagnostics in Clinical/Liquid Biopsy Applications, 2019-2026
Figure 17 : Global Market for CTC Diagnostics in Clinical/Liquid Biopsy Applications, by Region, 2019-2026
Figure 18 : Global Market for CTC Diagnostics in Research Applications, 2019-2026
Figure 19 : Global Market for CTC Diagnostics in Research Applications, by Region, 2019-2026
Figure 20 : Global Market for CTC Diagnostics, by Region, 2019-2026
Figure 21 : Global Market Shares of CTC Diagnostics, by Region, 2020
Figure 22 : North American Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 23 : North American Market Shares of CTC Diagnostics, by Country, 2020
Figure 24 : U.S. Market for CTC Diagnostics, 2019-2026
Figure 25 : Canadian Market for CTC Diagnostics, 2019-2026
Figure 26 : European Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 27 : European Market Shares of CTC Diagnostics, by Country, 2020
Figure 28 : German Market for CTC Diagnostics, 2019-2026
Figure 29 : French Market for CTC Diagnostics, 2019-2026
Figure 30 : U.K. Market for CTC Diagnostics, 2019-2026
Figure 31 : Italian Market for CTC Diagnostics, 2019-2026
Figure 32 : Spanish Market for CTC Diagnostics, 2019-2026
Figure 33 : Rest of European Market for CTC Diagnostics, 2019-2026
Figure 34 : Asia-Pacific Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 35 : Asia-Pacific Market Shares of CTC Diagnostics, by Country, 2020
Figure 36 : Chinese Market for CTC Diagnostics, 2019-2026
Figure 37 : Indian Market for CTC Diagnostics, 2019-2026
Figure 38 : Japanese Market for CTC Diagnostics, 2019-2026
Figure 39 : Australian Market for CTC Diagnostics, 2019-2026
Figure 40 : Rest of Asia-Pacific Market for CTC Diagnostics, 2019-2026
Figure 41 : Rest of World Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 42 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Net Revenue, 2016-2020
Figure 43 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Revenue Share, by Business Segment, 2020
Figure 44 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Revenue Share, by Region, 2020
Figure 45 : Biocept, Inc.: Net Revenue, 2016-2020
Figure 46 : Greiner Bio-One International GmbH: Net Revenue, 2016-2020
Figure 47 : Greiner Bio-One International GmbH: Revenue Share, by Business Segment, 2020
Figure 48 : Greiner Bio-One International GmbH: Revenue Share, by Region, 2020
Figure 49 : Qiagen: Net Revenue, 2016-2020
Figure 50 : Qiagen: Revenue Share, by Business Segment, 2020
Figure 51 : Qiagen: Revenue Share, by Region, 2020
Global Cancer Immunomodulator Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 95
The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 158
According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period.
The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......
Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 131
According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period.
The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......
Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 125
According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period.
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......
Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024
Published: 27-Dec-2023 Price: US 3350 Onwards Pages: 112
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......
Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 101
Market Overview of Global Cancer Gene Therapy market:
According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......
T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024
Published: 25-Dec-2023 Price: US 3350 Onwards Pages: 85
CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively.
The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......
Global Kaposi Sarcoma Market Status and Outlook 2023-2028
Published: 22-Dec-2023 Price: US 3160 Onwards Pages: 107
Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......
Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 21-Dec-2023 Price: US 3380 Onwards Pages: 118
Market Overview of Global Cancer Immunomodulator market:
According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
